Vertex Pharmaceuticals VRTX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $5.09B+11.3% | $4.57B-55.9% | $10.37B+235% | $3.1B-6.1% | ||
| $1.52B-1.5% | $1.55B+82.1% | $849.2M+209% | $274.5M-62.4% | ||
| $2.05B+27.6% | $1.61B+2.9% | $1.56B+8.4% | $1.44B+26.9% | ||
| $1.69B+39.9% | $1.21B+63.2% | $738.8M+60.4% | $460.6M+30.4% | ||
| $11.2B+16.7% | $9.6B-32.2% | $14.14B+6.9% | $13.23B+38.4% | ||
| $1.09B0.0% | $1.09B0.0% | $1.09B0.0% | $1.09B+8.6% | ||
| $25.64B+13.8% | $22.53B-0.9% | $22.73B+25.2% | $18.15B+35.1% | ||
| $461.7M+11.8% | $413M+13.2% | $364.9M+20.1% | $303.9M+55.8% | ||
| $3.86B+8.3% | $3.56B+0.5% | $3.55B+29.4% | $2.74B+28.0% | ||
| $6.98B+13.9% | $6.12B+18.9% | $5.15B+21.5% | $4.24B+27.2% | ||
| $13.56B+41.2% | $9.61B-5.3% | $10.14B+55.5% | $6.52B+104% | ||
| $18.67B+13.7% | $16.41B-6.7% | $17.58B+26.4% | $13.91B+37.7% | ||
| $25.64B+13.8% | $22.53B-0.9% | $22.73B+25.2% | $18.15B+35.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Vertex Pharmaceuticals's total assets?
- Vertex Pharmaceuticals (VRTX) holds $26.5B in total assets, up 15.8% year over year.
- How much debt does Vertex Pharmaceuticals have?
- Vertex Pharmaceuticals carries $2.0B in total debt against $19.4B of shareholders' equity, a debt-to-equity ratio of 0.10.
- How much cash does Vertex Pharmaceuticals have?
- Vertex Pharmaceuticals holds $5.5B in cash and equivalents.
- Can Vertex Pharmaceuticals cover its short-term obligations?
- Its current ratio is 3.02 — current assets exceed current liabilities.
- Where does Vertex Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Vertex Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
